Ashleigh Stewart

Ashleigh Stewart

By |2025-12-22T11:59:32+11:00December 22nd, 2025|Research Life|

Ashleigh Stewart is a Senior Research Coordinator at MIA, based at Macquarie University. Learn about her fascinating work in the liquid biopsy space, plus why working in the melanoma field is particularly important to her.

Comments Off on Ashleigh Stewart

Leon Burgess

By |2025-12-15T11:16:23+11:00December 15th, 2025|Research Life|

Leon Burgess is a Biobank Technical Officer at Melanoma Institute Australia (MIA). In his 'Research Life' answers he dives into career highlights, what he loves about his work, his favourite quote and more.

Comments Off on Leon Burgess

Assoc Prof Inês da Silva receives two prestigious awards in one night!

By |2025-12-04T08:45:56+11:00December 4th, 2025|Research News|

Assoc Prof Inês da Silva, Medical Oncologist & Senior Researcher at MIA, was recently presented with the inaugural 'Marie Krogh Young Women in Science Prize' and the 'NSW Premier’s Awards Outstanding Mid-Career Researcher of the Year', in recognition of her groundbreaking contributions to melanoma treatment and care.

Comments Off on Assoc Prof Inês da Silva receives two prestigious awards in one night!

Dr Nurudeen Adegoke

By |2025-11-11T10:46:09+11:00November 11th, 2025|Research Life|

Nurudeen Adegoke is MIA’s Senior Data Scientist and Biostatistician. He is also an Honorary Senior Lecturer at USyd and an Accredited Statistician with the Statistical Society of Australia. Read more about his personal and professional life.

ESMO 2025

By |2025-10-23T10:44:33+11:00October 23rd, 2025|Research News|

Leading Melanoma Institute Australia clinicians and researchers are in Europe to share latest research findings and clinical updates with international colleagues as we continue our efforts to reach zero deaths from melanoma.

Comments Off on ESMO 2025

Adjuvant vs Neoadjuvant – Further evidence for pre-surgery immunotherapy

By |2025-10-29T17:44:37+11:00October 22nd, 2025|Research News|

Results of the RELATIVITY-098 clinical trial published in Nature Medicine show the presence of tumour is directly related to the effectiveness of combination immunotherapy for high risk and advanced melanoma, providing more evidence that neoadjuvant immunotherapy is the new frontier in treatment for melanoma, and other cancers.

Comments Off on Adjuvant vs Neoadjuvant – Further evidence for pre-surgery immunotherapy

Vikki Steel

By |2025-10-14T10:42:30+11:00October 14th, 2025|Research Life|

Vikki Steel is the Clinical Research Associate Team Leader in the Investigator Led Clinical Trials team at Melanoma Institute Australia. Learn about her professional journey and her life outside of work here!

Comments Off on Vikki Steel

Dr Esther Lim

By |2025-10-08T15:13:34+11:00October 8th, 2025|Research Life|

Esther Lim is a Cancer & Immune Cell Biologist at Melanoma Institute Australia, based at Macquarie University. Read more about her latest research and personal life!

Comments Off on Dr Esther Lim
Go to Top